Trending Now
MannKind Corporation (NASDAQ: MNKD) Starts Paediatric Enrolment For INHALE-1 Study ...
MannKind Corporation (NASDAQ: MNKD) has announced the enrolment of the first pediatric subject in its INHALE -1 trial. This multi-site study will assess the...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Is the Stock Market Gearing Up for a Year-End Surprise?
The financial world is buzzing with an intriguing prediction: we might just witness a year-end stock market rally that overshadows all Wall...
MAKE IT MODERN
LATEST REVIEWS
EyePoint Pharmaceutical Inc. (NASDAQ:EYPT) Reports Revenue Of $15.7 Million In Q3...
EyePoint Pharmaceutical Inc. (NASDAQ:EYPT) has announced Q3 2020 financial results and provided its recent corporate development updates.
DEXYCU and YUTIQ net sales of $5.8 million
The...
MAKE IT MODERN
PERFORMANCE TRAINING
Heron Therapeutics Inc. (NASDAQ:HRTX) Resubmits HTC-011 New Drug Application To The FDA
Heron Therapeutics Inc. (NASDAQ:HRTX) has announced the resubmission of the New Drug Application for HTX-011 to the US FDA. HTX-011 is an...
Silvergate Capital Corp (NYSE:SI) Dramatic Surge: Exploring Potential Causes and Future Prospects Amid Industry...
Silvergate Capital Corp (NYSE: SI) experienced a significant increase of 52.21%, with its value rising from 1.7200 to 2.3100. The stock's prior...
MEIP Stock sees a Significant Surge Amidst Strategic Evaluation
Shares of MEI Pharma, Inc. (NASDAQ: MEIP) experienced a remarkable 21.33% increase today, closing at $3.47. The momentum continued after hours, with...
Insmed (NASDAQ: INMD) Shares Surge as New Drug Shows Promise
Insmed Incorporated (NASDAQ: INSM) witnessed a dramatic surge in its stock price following the release of promising results from its latest drug...
The FDA Has Increased The Review Time For Amylyx Pharmaceuticals Inc’s (NASDAQ: AMLX) ALS...
The U.S Food and Drug Administration (FDA) has increased the review time for Amylyx Pharmaceuticals Inc's (NASDAQ: AMLX) experimental amyotrophic therapy for lateral sclerosis....
MAKE IT MODERN
